Amgen Inc (NASDAQ:AMGN)

243.87
Delayed Data
As of 4:00pm ET
 -1.30 / -0.53%
Today’s Change
214.39
Today|||52-Week Range
296.67
-7.15%
Year-to-Date
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
Feb 04 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Q4 Earnings Top, 2023 View Disappoints, Stock Down
Jan 31 / Zacks.com - Paid Partner Content
Capital Wealth Planning, LLC Buys 2, Sells 3 in 4th Quarter
Feb 03 / GuruFocus News - Paid Partner Content
Is a Surprise Coming for Amgen (AMGN) This Earnings Season?
Jan 30 / Zacks.com - Paid Partner Content
Top 5 4th Quarter Trades of First Dallas Securities Inc.
Feb 03 / GuruFocus News - Paid Partner Content
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know
Jan 26 / Zacks.com - Paid Partner Content
Why Amgen Stock Wilted on Wednesday
Feb 01 / MotleyFool.com - Paid Partner Content
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Jan 26 / Zacks.com - Paid Partner Content
Amgen (AMGN) Beats on Q4 Earnings, 2023 Sales View Disappoints
Feb 01 / Zacks.com - Paid Partner Content
2 Top Biotech Stocks to Buy for the Long Haul
Jan 26 / MotleyFool.com - Paid Partner Content
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Feb 01 / Zacks.com - Paid Partner Content
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
Jan 25 / Zacks.com - Paid Partner Content
Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics
Feb 01 / Zacks.com - Paid Partner Content
Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?
Jan 25 / Zacks.com - Paid Partner Content
Amgen (AMGN) Surpasses Q4 Earnings and Revenue Estimates
Jan 31 / Zacks.com - Paid Partner Content